The emerging role of antibody-drug conjugates in EGFR-mutant non-small cell lung cancer with acquired resistance to third-generation EGFR tyrosine kinase inhibitors
1. 系统已在2026-03-05 10:02:15对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.jconrel.2026.114747
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0168365926001495
其他信息:
出版社: Elsevier BV
作者: Yi-Chen Zhang; Wei-Chi Luo; Jia-Ting Li; Lv Wu; Zhi-Hong Chen; Qing Zhou

